Chronic Kidney Disease: The value of the uACR Test for Early Identification of Cardio-Renal Risk

The event will convene national and regional press and policymakers to respond to the need to bridge the gap between scientific evidence and clinical practice in the use of uACR (urinary albumin-to-creatinine ratio). 

The project aims to understand the barriers to its use and identify ways to support broader implementation. The event launches a multi-stakeholder position paper to improve awareness of uACR ad support the early diagnosis of CKD and management of cardiovascular risk.